Koers Suven Pharmaceuticals Limited Bombay S.E.
Aandelen
SUVENPHAR
INE03QK01018
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
713 INR | -1,50% | -1,11% | -1,81% |
19/06 | Transcript : Sapala Organics Private Limited, Suven Pharmaceuticals Limited - M&A Call | |
14/06 | Suven Pharmaceuticals neemt 67,5% belang in Sapala Organics | MT |
Omzet 2024 | 10,51 mld. 126 mln. 118 mln. | Omzet 2025 * | 11,53 mld. 138 mln. 129 mln. | Marktkapitalisatie | 182 mld. 2,18 mld. 2,03 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | 3 mld. 35,95 mln. 33,61 mln. | Nettowinst (verlies) 2025 * | 3,4 mld. 40,75 mln. 38,1 mln. | EV/omzet 2024 | 16,4 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 15,8 x |
K/w-verhouding 2024 |
57,4
x | K/w-verhouding 2025 * |
53,3
x | Werknemers | 1.193 |
Dividendrendement 2024 * |
0,25% | Dividendrendement 2025 * |
0,21% | Vrij verhandelbaar | 87,58% |
Recentste transcriptie over Suven Pharmaceuticals Limited
1 dag | -1,50% | ||
1 week | -1,11% | ||
Lopende maand | +14,50% | ||
1 maand | +14,69% | ||
3 maanden | +9,84% | ||
6 maanden | -0,51% | ||
Lopend jaar | -1,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 29-09-23 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | 01/01 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 67 | 29-09-23 | |
Shweta Jalan
BRD | Director/Board Member | 48 | 09/11 |
Director/Board Member | 62 | 09/11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
21-06-24 | 713 | -1,50% | 6 355 |
20-06-24 | 723,8 | -1,54% | 19 807 |
19-06-24 | 735,2 | -1,57% | 5 728 |
18-06-24 | 746,8 | +3,59% | 46 438 |
14-06-24 | 721 | +8,06% | 30 425 |
uitgestelde koers Bombay S.E., 21 juni 2024 om 12:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,63% | 796 mld. | |
+41,51% | 628 mld. | |
-5,10% | 358 mld. | |
+19,90% | 331 mld. | |
+9,95% | 301 mld. | |
+17,66% | 244 mld. | |
+3,39% | 228 mld. | |
+10,75% | 214 mld. | |
+6,99% | 165 mld. |
- Beurs
- Aandelen
- Koers SUVENPHAR
- Koers SUVENPHAR